Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Dacarbazine With or Without Allovectin-7 in Patients With Metastatic Melanoma

NCT00003647 is registered in ClinicalTrials.gov with Vical as lead sponsor.

NCT NCT00003647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Dacarbazine With or Without Allovectin-7 in Patients With Metastatic Melanoma
Lead sponsor
Vical
Phase
Phase 3
Overall status
Completed
Start date
July 31, 1998
Completion date
September 30, 2002
Enrollment
Not reported
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent melanoma, stage iii melanoma, stage iv melanoma